Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

TTOO's 375% Surge In A Month: Unveiling the Driving Forces

T2 Biosystems Stock price

The small-cap penny stock market has been hot lately, with a surge in volume and activity across several names. The most in-play name, with price and volume soaring remarkably, has been T2 Biosystems (NASDAQ: TTOO). Over the past month, shares of this small-cap healthcare stock have soared over 375%. The looming question is whether the surge will continue for TTOO, or should investors be on alert and want to ring the register?

What Is T2 Biosystems?

T2 Biosystems develops diagnostic products to detect pathogens and abnormalities in unpurified patient samples. They offer instruments like T2Dx for running tests and panels such as T2Candida, T2Bacteria, and T2SARS-CoV-2 for identifying infections. They're also working on panels for biothreats, sepsis, Candida auris, and Lyme disease. Founded in 2006, the company is based in Lexington, Massachusetts.

T2 Biosystems MarketRank Score

The company has a market capitalization of $195.44 million, a free float of 333 million, an average volume of 40.14 million, and a 52-week range of $0.05 and $7.63.

The Three Catalysts Behind The Move

1) On July 31, TTOO announced that The Nasdaq Hearings Panel had granted an extension to the company until November 20, 2023, to meet Nasdaq's requirements regarding minimum bid price and market value of listed securities. 

The company must achieve a closing bid price of at least $1.00 per share and a market value of at least $35 million for ten consecutive business days by that date to comply with the rules. TTOO will actively monitor its stock price and market value during this extension period and consider various options, including a potential reverse stock split, to address the deficiency and maintain its listing. However, timely compliance with the Panel's decision is not guaranteed.

2) On August 7, the company reported financial results for its second quarter. In the second quarter, the company's total revenue was $2 million, down 67% from the previous year, mainly due to a decrease in BARDA research contribution revenues by $3.4 million. Sepsis test panel revenue reached $1.3 million, a 7% increase compared to the previous year, despite a $350 thousand sepsis test backorder at the end of the quarter.

They improved their balance sheet by converting $10 million of term loan debt with CRG Servicing LLC into T2 Biosystems equity. As of June 30, 2023, the company had $16.1 million in cash and cash equivalents and raised $10.9 million in net proceeds through ATM sales in the third quarter.

The company also announced that they received FDA Breakthrough Device designation for Candida auris direct-from-blood molecular diagnostic test.

3) Short Interest and Retail Favorite 

The third catalyst, arguably the one which holds the most weight, at least in the short term, has been the stock's popularity amongst retail traders and the rising short interest. 

T2 Biosystems short interest

Month over month, as of July 31, the short volume increased by 716.23%, from 1.9m shares to 15.5m shares. As the stock has continued to climb, along with a sustained surge in volume, it's likely so too has the short interest. 

The average daily volume of TTOO is 40.62 million shares. However, as the stock has gained popularity and was dubbed a meme stock by many, beginning in late July, the volume has rocketed higher. Since above-average volume first entered the stock in July, it has only traded less than its average daily volume on thirteen out of the last thirty days, with many of those days seeing volume surge over 100 million.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.